Cargando…

Insertable cardiac monitoring results in higher rates of atrial fibrillation diagnosis and oral anticoagulation prescription after ischaemic stroke

AIMS: After an ischaemic stroke, atrial fibrillation (AF) detection allows for improved secondary prevention strategies. This study aimed to compare AF detection and oral anticoagulant (OAC) initiation in patients with an insertable cardiac monitor (ICM) vs. external cardiac monitor (ECM) after isch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boriani, Giuseppe, Auricchio, Angelo, Botto, Giovanni Luca, Joseph, Jennifer M, Roberts, Gregory J, Grammatico, Andrea, Nabutovsky, Yelena, Piccini, Jonathan P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403249/ https://www.ncbi.nlm.nih.gov/pubmed/37490349 http://dx.doi.org/10.1093/europace/euad212

Ejemplares similares

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation?
por: Induruwa, Isuru, et al.
Publicado: (2022)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
por: O'Neal, Wesley T., et al.
Publicado: (2018)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
por: Mahnkopf, Christian, et al.
Publicado: (2021)

Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study
por: Wilson, Duncan, et al.
Publicado: (2019)

Ischaemic stroke in the absence of documented atrial fibrillation: is there who could benefit from anticoagulant therapy?
por: Vassiliki’ Coutsoumbas, Gloria, et al.
Publicado: (2022)

The link between ischaemic stroke, ischaemic heart disease, and atrial fibrillation
por: El-Battrawy, Ibrahim, et al.
Publicado: (2023)

Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation
por: Polymeris, Alexandros A, et al.
Publicado: (2022)

Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China
por: Gu, Hong-Qiu, et al.
Publicado: (2021)

Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation
por: Chopard, Romain, et al.
Publicado: (2018)

Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation
por: Hellwig, Simon, et al.
Publicado: (2018)

Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation
por: Carlisle, Matthew A., et al.
Publicado: (2022)

Atrial fibrillation and ischaemic heart disease: should we use acetylsalicylic acid beside anticoagulants?
por: Volpe, Massimo, et al.
Publicado: (2020)

Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy
por: Mittal, Suneet, et al.
Publicado: (2017)

Could Some Geriatric Characteristics Hinder the Prescription of Anticoagulants in Atrial Fibrillation in the Elderly?
por: Denoël, Paule, et al.
Publicado: (2014)

Assessment of an Algorithm for Prescription of Oral Anticoagulation for Patients With Atrial Fibrillation in Emergency Departments
por: Atzema, Clare L., et al.
Publicado: (2020)

Frailty and oral anticoagulant prescription in adults with atrial fibrillation: A systematic review
por: Bul, Mary, et al.
Publicado: (2022)

Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients
por: Arnold, Martin, et al.
Publicado: (2023)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation
por: Meinel, Thomas R., et al.
Publicado: (2020)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
por: Kapadia, Meera, et al.
Publicado: (2023)

Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality
por: Botto, Giovanni Luca, et al.
Publicado: (2021)

Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA
por: Wilson, Duncan, et al.
Publicado: (2019)

Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study
por: Wilson, Duncan, et al.
Publicado: (2018)

Evaluation of anticoagulation status for atrial fibrillation on early ischaemic stroke outcomes: a registry-based, prospective cohort study of acute stroke care in Surrey, UK
por: Han, Thang S, et al.
Publicado: (2017)

Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world
por: Kozieł, Monika, et al.
Publicado: (2021)

Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients between 2004 and 2019
por: Gorczyca-Głowacka, Iwona, et al.
Publicado: (2022)

Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?
por: Cao, Lin, et al.
Publicado: (2015)

Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants
por: Purrucker, Jan C., et al.
Publicado: (2020)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2021)

Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation
por: Botto, Gianluca, et al.
Publicado: (2021)

Association Between Left Atrial Appendage Morphology and Function and the Risk of Ischaemic Stroke in Patients with Atrial Fibrillation
por: Dudziñska-Szczerba, Katarzyna, et al.
Publicado: (2022)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function
por: de Jong, Ype, et al.
Publicado: (2021)

Low prevalence of atrial fibrillation in ischaemic stroke: Underestimating a modifiable risk factor
por: Mayet, Mohammed, et al.
Publicado: (2021)

Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants
por: Jhawar, Manish B, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_963k47girkcjipem5h2i4hfemk